High-Density Lipoprotein-like Magnetic Nanostructures (HDL-MNS): Theranostic Agents for Cardiovascular Disease
- Creators
- Nandwana, Vikas
Abstract
We report the development of potential theranostic agents for cardiovascular disease that are based on high-density lipoprotein-like magnetic nanostructures (HDL-MNS). The HDLMNS oer prospects for diagnosis via noninvasive magnetic resonance imaging for anatomic detection and also serve as eective cholesterol eux agents to address atherosclerotic vascular lesions. The HDL-MNS are synthesized by adding phospholipids and the HDL-dening apolipoprotein A1 to the surface of magnetic nanostructures (MNS) to mimic some aspects of natural HDL particles. From a diagnostic perspective, HDLMNS show a 5 times higher contrast (r2 relaxivity up to 383 mM1 s1) in magnetic resonance imaging (MRI) than commercially available T2 MRI contrast agents (e.g., Ferumoxytol). Internalization of HDL-MNS by macrophage cells was conrmed by transmission electron microscopy (TEM), energy dispersive X-ray spectroscopy (EDX), inductive-coupled plasma mass spectrometry (ICP-MS), and successfully imaged via MRI. Also, the HDLMNS particles show capacity to induce cholesterol eux (4.8%) from macrophage cells comparable to natural HDL (4.7%), providing a pathway to prevent and treat cardiovascular disease via reverse cholesterol transport. The ability to image macrophage cells that have internalized HDL-MNS along with the cholesterol eux capacity demonstrates the potential of the HDL-MNS particles as theranostic agents.
Files
Name | Size | Download all |
---|---|---|
md5:4dde815464af46fa3afceb356fc7bf51
|
2.6 MB | Preview Download |
Additional details
- ARK
- ark:/c8131/g3mj0x
- Created
-
2017When the item was originally created.